# Internal Review (Round 1)

**Reviewer:** Claude Code (self-review)
**Date:** 2026-03-09

## Verdict: MINOR REVISION

## Strengths
1. **Clear research question** with immediate policy relevance — ERPO laws and suicide are among the most debated public health issues
2. **Rigorous methodology** — Callaway-Sant'Anna staggered DiD is the correct choice for this setting
3. **Striking TWFE bias demonstration** — the sign flip between TWFE (-1.19) and CS-DiD (+0.24) is a textbook illustration of heterogeneous treatment effect bias
4. **Honest reporting** — the null result is presented assertively without apologetics
5. **Strong institutional background** — the paper explains ERPO mechanisms, staggered adoption, and implementation heterogeneity well
6. **Good placebo test** — drug overdose deaths as a falsification outcome is creative and well-motivated

## Weaknesses
1. **Non-firearm suicide SE (0.018)** — This is implausibly small and likely a computational artifact. The paper now has a footnote caveat, but the underlying issue should be investigated further.
2. **Short-panel vs combined-panel tension** — The combined panel gives a null, the short panel gives a significant positive. The paper now reconciles this, but the tension weakens the narrative.
3. **2018 gap** — Eight states treated in 2018 have no t=0 observation. The paper acknowledges this but the limitation is structural.
4. **Limited heterogeneity analysis** — Gun ownership heterogeneity analysis failed due to small sample sizes. This is a genuine limitation.

## Minor Issues
- Table 1 Panel B includes all 51 jurisdictions while Table 2 uses 38 (pre-2019 adopters excluded) — now reconciled in table notes
- The power section could be more precise about the MDE calculation

## Recommendation
The paper is ready for external review. The null finding with strong TWFE comparison is the main contribution. The short-panel mechanism decomposition is suggestive but should not be over-interpreted.
